vimarsana.com
Home
Live Updates
Trial highlight single agent
Live Breaking News & Updates on Trial Highlight Single Agent
Stay updated with breaking news from Trial highlight single agent. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Alkermes plc: Alkermes Presents New Nemvaleukin Alfa Monotherapy Data at the American Society of Clinical Oncology Genitourinary Cancers Symposium
- Data From ARTISTRY-1 Clinical Trial Highlight Single-Agent, Anti-Tumor Activity of Nemvaleukin in Patients With Renal Cell Carcinoma - DUBLIN, Feb. 17, 2022 /PRNewswire/ Alkermes ....
United States
,
Emiliano Calvo
,
Craig Hopkinson
,
Sandy Coombs
,
Sourojit Bhowmick
,
American Society Of Clinical Oncology
,
Research Development At Alkermes
,
Merck Sharp Dohme Corp
,
Exchange Commission
,
Nemvaleukin Clinical Development Program
,
Merck Co Inc
,
Clinical Research
,
Trial Highlight Single Agent
,
Anti Tumor Activity
,
Patients With Renal Cell Carcinoma
,
American Society
,
Clinical Oncology
,
Cancers Symposium
,
Chief Medical Officer
,
Executive Vice President
,
Nemvaleukin Alfa
,
Patients With Advanced Renal Cell Carcinoma
,
Medical Oncologist
,
Centro Integral Oncol
,
Clara Campal Hospital
,
Nemvaleukin Clinical Development
,